期刊
JOURNAL OF THE AMERICAN HEART ASSOCIATION
卷 5, 期 2, 页码 -出版社
WILEY-BLACKWELL
DOI: 10.1161/JAHA.115.002767
关键词
atherosclerosis; cardiovascular disease; endothelial cell; inflammation; leukocyte adhesion; nuclear factor-kappa B signaling; trimethylamine N-oxide; vascular smooth muscle cell
资金
- NIH [HL28481, R01HL103866, P20HL113452, R01 HL103866 06A1, R01 DK106000, 2 P01 HL030568-31A1]
- Office of Dietary Supplements [T32HL69766, HL30568]
- Leonard Krieger Fund
- AB SCIEX Center of Innovation Award
Background-The choline-derived metabolite trimethylamine N-oxide (TMAO) has been demonstrated to contribute to atherosclerosis and is associated with coronary artery disease risk. Methods and Results-We explored the impact of TMAO on endothelial and smooth muscle cell function in vivo, focusing on disease-relevant outcomes for atherogenesis. Initially, we observed that aortas of LDLR-/- mice fed a choline diet showed elevated inflammatory gene expression compared with controls. Acute TMAO injection at physiological levels was sufficient to induce the same inflammatory markers and activate the well-known mitogen-activated protein kinase, extracellular signal-related kinase, and nuclear factor-kappa B signaling cascade. These observations were recapitulated in primary human aortic endothelial cells and vascular smooth muscle cells. We also found that TMAO promotes recruitment of activated leukocytes to endothelial cells. Through pharmacological inhibition, we further showed that activation of nuclear factor-kappa B signaling was necessary for TMAO to induce inflammatory gene expression in both of these relevant cell types as well as endothelial cell adhesion of leukocytes. Conclusions-Our results suggest a likely contributory mechanism for TMAO-dependent enhancement in atherosclerosis and cardiovascular risks.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据